Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05228119
What this trial is testing

Oncolytic Virus Injection (RT-01) in Combination With PD-1 Inhibitor in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
The Affiliated Hospital of Xuzhou Medical University 50
Not applicableUnknownNCT05123287
What this trial is testing

A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up

Who this might be right for
Plaque, AtheroscleroticImmune Checkpoint InhibitorsProgrammed Cell Death Protein 1 Inhibitor+2 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Large-scale testing (Phase 3)Looking for participantsNCT07235319
What this trial is testing

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC

Who this might be right for
Nasopharangeal CancerDistant Metastasis
Sun Yat-sen University 260
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07683507
What this trial is testing

Becotatug Vedotin Plus PD-1 Inhibitor for Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Feng Liu 60
Testing effectiveness (Phase 2)Temporarily pausedNCT04042116
What this trial is testing

Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor

Who this might be right for
Advanced Solid TumorGynecologic Cancer
Clovis Oncology, Inc. 227
Early research (Phase 1)UnknownNCT05735028
What this trial is testing

The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer

Who this might be right for
Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 8
Not applicableLooking for participantsNCT06740370
What this trial is testing

TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTranscatheter Arterial ChemoembolizationAnti-PD1 Antibody+1 more
Sun Yat-sen University 32
Not applicableUnknownNCT05310305
What this trial is testing

PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer

Who this might be right for
Immune Checkpoint InhibitorsAnti-programmed Death-1 AntibodyRadiotherapy+7 more
Lei Li 20
Not applicableUnknownNCT06607120
What this trial is testing

Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 950
Testing effectiveness (Phase 2)Study completedNCT05275023
What this trial is testing

An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants

Who this might be right for
Hepatitis B, Chronic
Janssen Research & Development, LLC 37
Not applicableStudy completedNCT06195254
What this trial is testing

Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer

Who this might be right for
Stereotactic Body RadiotherapyPD-1 InhibitorsPancreatic Cancer
Peking University Third Hospital 19
Testing effectiveness (Phase 2)UnknownNCT03656094
What this trial is testing

Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 Inhibitors

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Samsung Medical Center 98
Testing effectiveness (Phase 2)Looking for participantsNCT06965231
What this trial is testing

Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial

Who this might be right for
Melanoma of SkinAcral MelanomaStage II Melanoma
Fudan University 58
Early research (Phase 1)Active Not RecruitingNCT04572451
What this trial is testing

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma

Who this might be right for
MelanomaUnresectable Solid TumorsNeoplasms+7 more
Yana Najjar 50
Testing effectiveness (Phase 2)UnknownNCT04297202
What this trial is testing

SHR-1210 Combined With Apatinib Mesylate in the Perioperative Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Testing effectiveness (Phase 2)UnknownNCT03544723
What this trial is testing

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Who this might be right for
Solid TumorLymphoma
MultiVir, Inc. 40
Not applicableUnknownNCT04782622
What this trial is testing

The Combination of Apatinib and Camerlizumab for Advanced Lung Cancer Patients With Muti-line Therapy

Who this might be right for
Lung Cancer
The Affiliated Hospital of Qingdao University 60
Not applicableUnknownNCT06505486
What this trial is testing

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 21
Testing effectiveness (Phase 2)Study completedNCT03939975
What this trial is testing

Anti-PD-1therapy Combined With Thermal Ablation for Advanced HCC

Who this might be right for
Carcinoma, Hepatocellular
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04139902
What this trial is testing

Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Diwakar Davar 48
Next Page